Aug. 3 at 10:58 AM
$ESTA
Huge PT increase ahead of earnings.
Establishment Labs (NASDAQ: ESTA)
Buy (1)
Price Target:
$117.00 (Prior
$95.00)
Augmenting Our Thesis with a Bullish 2Q Call
THE TD COWEN INSIGHT
We see opportunities for broad-based revenue outperformance in 2Q, but remain most confident about the U.S. setup. Ramping momentum in the U.S. Motiva/Preservé launches and OUS minimally invasive rollouts underpin our bullish 2026 revenue upside thesis, and we continue to view the margin setup as achievable barring additional sales force spend post-recon approval. Reiterate Buy, PT to
$117.